Ciornei Radu Tudor, Hong So-Hee, Fang Yujiang, Zhu Ziwen, Braley-Mullen Helen
Department of Medicine, University of Missouri, Columbia, MO 65212, United States.
Department of Surgery, University of Missouri, Columbia, MO 65212, United States; Department of Microbiology, Immunology and Pathology, Des Moines University, Des Moines, IA 50312, United States.
Cell Immunol. 2016 Jun-Jul;304-305:16-26. doi: 10.1016/j.cellimm.2016.04.006. Epub 2016 Apr 22.
IFN-γ(-/-) NOD.H-2h4 mice develop autoimmune disease with extensive hyperplasia and proliferation of thyroid epithelial cells (TEC H/P) and fibrosis. Splenic T cells from donors with severe TEC H/P transfer TEC H/P to SCID recipients. The goal of this study was to determine what factors control TEC H/P development/progression by examining T cells, markers of apoptosis, senescence and proliferation in thyroids of SCID recipients over time. At 28days, T cell infiltration was maximal, thyrocytes were proliferating, and fibrosis was moderate. At days 60 and 90, thyroids were larger with more fibrosis. T cells, cytokines and thyrocyte proliferation decreased, and cell cycle inhibitor proteins, and anti-apoptotic molecules increased. T cells and thyrocytes had foci of phosphorylated histone protein H2A.X, indicative of cellular senescence, when TEC H/P progressed and thyrocyte proliferation declined. Some thyrocytes were regenerating at day 90, with irregularly shaped empty follicles and ciliated epithelium. Proliferating thyrocytes were thyroid transcription factor (TTF1)-positive, suggesting they derived from epithelial cells and not brachial cleft remnants.
IFN-γ(-/-) NOD.H-2h4小鼠会发展出自身免疫性疾病,伴有甲状腺上皮细胞广泛增生和增殖(TEC H/P)以及纤维化。患有严重TEC H/P的供体的脾脏T细胞将TEC H/P转移给SCID受体。本研究的目的是通过随时间检查SCID受体甲状腺中的T细胞、凋亡、衰老和增殖标志物,来确定控制TEC H/P发展/进展的因素。在第28天,T细胞浸润达到最大值,甲状腺细胞增殖,纤维化程度中等。在第60天和第90天,甲状腺更大,纤维化更严重。T细胞、细胞因子和甲状腺细胞增殖减少,细胞周期抑制蛋白和抗凋亡分子增加。当TEC H/P进展且甲状腺细胞增殖下降时,T细胞和甲状腺细胞有磷酸化组蛋白H2A.X的病灶,表明细胞衰老。在第90天,一些甲状腺细胞正在再生,有形状不规则的空滤泡和纤毛上皮。增殖的甲状腺细胞甲状腺转录因子(TTF1)呈阳性,表明它们来源于上皮细胞而非鳃裂残余物。